Purpose and aims

Active pharmaceutical ingredient: armodafinil. The trade name Artvigil is used by some international manufacturers for tablets that contain this wakefulness-promoting agent. Armodafinil is prescribed to reduce excessive sleepiness in adults with narcolepsy, to address daytime sleepiness related to obstructive sleep apnea when primary treatment does not fully control symptoms, and for shift work sleep disorder.

Artvigil tablets are frequently produced as 150 mg units by several overseas suppliers. Equivalent preparations and approved generics contain the same active molecule and may be available in other strengths. For dosing recommendations see the dosing guidelines below at administration and dosing.

Clinicians often use armodafinil in combination with definitive therapies for the underlying condition. For example, it may be added to continuous positive airway pressure treatment for OSA when sleepiness persists. Some people pursue off-label use for enhanced alertness during study or work; review the law and regulatory considerations and safety reminders before considering nonapproved uses.

Administration practices and dosing

Follow what your prescriber has advised. The regimens below reflect common adult practice but individual dosing should be tailored by a clinician.

  • For shift work sleep disorder: typically a single 150 mg dose about one hour before the start of the work shift.
  • For narcolepsy or residual sleepiness from OSA: many prescribers use 150 mg in the morning; some patients require up to 250 mg once daily depending on response and tolerability.
  • Most patients take armodafinil once per day in the morning to avoid interference with nighttime sleep.
  • Taking the tablet with food is acceptable; however a heavy meal may delay the onset of action.
  • Duration of therapy is individualized. Clinicians commonly reassess benefit and undesirable effects after several weeks and may adjust or stop treatment based on outcomes.

Keep dosing times consistent to minimize sleep disruption at night. Until you understand how armodafinil affects you, use caution when driving or operating machinery; see clinical circumstances that negate use and cautions for additional safety pointers.

Pregnancy, contraception, and recommended precautions

Tell your prescriber about all health problems, prescription drugs, over-the-counter medicines, herbal products, and a past history of substance misuse before starting armodafinil. Extra vigilance is needed with these conditions:

  • Liver disease or kidney diseases or reduced organ function.
  • Cardiac disease, prior heart attack, structural heart problems, or poorly controlled high blood pressure.
  • History of mood disorders, psychosis, severe anxiety, or substance dependence.
  • Pregnancy, planned pregnancy, or breastfeeding status.

Important contraception information: armodafinil can lower the effectiveness of hormonal contraceptives during treatment and for up to four weeks after stopping. Use a reliable nonhormonal backup method while taking armodafinil and for four weeks after discontinuation. Look over the back and forth of communication log at medication-drug the exchange between people checks and effects.

Important contraindicating factors in clinical decisions and safety precautions

  • Do not take armodafinil if you have had a severe rash or allergic reaction to armodafinil, modafinil, Nuvigil, or Provigil previously.
  • Avoid consuming alcohol with armodafinil because combined effects can be unpredictable.
  • Do not drive or perform hazardous tasks until you know how armodafinil affects your alertness.
  • If you develop a widespread rash, blistering, mouth ulcers, or signs of anaphylaxis, stop the medicine and seek immediate medical attention.

Athletes and competitive participants should confirm current anti-doping rules, since modafinil and armodafinil may be subject to restrictions; consult legal and sport guidance for further information, read the article FAQ.

Commonly reported negative effects and urgent warning signs

Mild to moderate adverse consequences are common and often lessen over time. Typical complaints include a headache, difficulty initiating sleep, nausea, and dizziness.

  • Headache pain
  • Sleep deprivation or difficulty falling asleep
  • Nausea and a queasy stomach
  • A sensation of dizziness or lightheadedness

Seldom but grave. reactions need urgent medical attention. Stop the drug and seek emergency care if you notice any of the following:

  • Severe skin reactions such as blistering, rapidly spreading rash, or peeling skin
  • Fever with sore throat, swollen glands, or red painful eyes
  • Swelling of face, lips, tongue, or throat
  • New or severe breathing difficulties or hoarseness
  • Chest pain, sudden leg swelling, or yellowing of the skin
  • New or worsening psychiatric symptoms such as hallucinations, extreme agitation, or suicidal thoughts
  • Marked changes in heart rhythm or very rapid heartbeat

Serious cutaneous reactions typically appear early in treatment. Discontinue at the first sign of a rash and contact your healthcare provider immediately.

Drug interactive engagement monitoring and pharmacologic effects

Armodafinil affects several liver enzymes and can change concentrations of many medicines. Provide a complete medication list to your prescriber and pharmacist, including vitamins and herbal products.

  • CYP3A4 induction: armodafinil may reduce blood levels of drugs metabolized by CYP3A4, such as some statins, certain immunosuppressants, and hormonal contraceptives.
  • Strong CYP3A4 inhibitors, for example ketoconazole or itraconazole, can increase armodafinil exposure.
  • CYP2C19 inhibition: armodafinil can raise levels of CYP2C19 substrates including omeprazole, diazepam, propranolol, and phenytoin.
  • Because of the contraceptive the reciprocal contact between individuals, use an additional nonhormonal birth control method while taking armodafinil and for four weeks after stopping.

If you are unsure whether a medicine interacts with armodafinilplease confirm. with your prescriber or pharmacist before making changes to your treatment.

Missed precise dosing guidance and steps

If you forget a scheduled dose, take it as soon as you remember only if you will be awake for several more hours. If it is close to bedtime, skip the forgot to take the dose and resume the normal schedule the next day. Do not attempt to compensate for a forgot to take the dose by doubling the dose.

An having an overdose: recognition and recommended actions

If you suspect an drug overdose, contact emergency services or your local emergency number immediately.

Possible overdose symptoms include extreme agitation or restlessness, severe confusion or hallucinations, persistent vomiting or diarrhea, chest pain, breathing difficulty, and abnormal or very rapid heart rhythm.

Storage area network and handling operations

  • Store at room temperature, for example between 68 and 77 F, and protect from excessive heat and moisture.
  • Keep all medicines out of the reach of children and pets and retain packaging to preserve labeling and expiration knowledge.

Additional pathways with a concise comparisons

Several other agents are used to promote wakefulness or manage excessive daytime sleepiness. Choice depends on diagnosis, comorbid conditions, cost, and system monitoring requirements.

  • Nuvigil and FDA approved generic armodafinil: these contain the same active ingredient as Artvigil and are the approved armodafinil options in the United States.
  • Provigil and generic modafinil: modafinil is a related compound; standard adult dosing is usually 200 mg once daily.
  • Sunosi (solriamfetol): a dopamine and norepinephrine reuptake inhibitor; effective for OSA and narcolepsy but may increase blood pressure and heart rate.
  • Wakix (pitolisant): a histamine H3 receptor antagonist/inverse agonist indicated for narcolepsy; typically not a controlled substance but often expensive.
  • Traditional stimulants: methylphenidate or amphetamine formulations can be used off label for sleepiness but have greater abuse potential and stricter regulation.

Discuss these options with a sleep specialist or prescribing clinician to compare efficacy, side effects, surveillance of system activity needs, and cost. For price notes see anticipated costs and promotional pricing in USD.

Pricing estimates in USD

Retail costs vary widely with pharmacy, insurance coverage, coupons, and whether a brand or generic product is obtained. The ranges below are approximate monthly costs for typical adult dosing in the United States.

  • Nuvigil (brand armodafinil) 150 mg, 30 tablets: roughly 600 to 900 USD without insurance.
  • Generic armodafinil 150 mg, 30 tablets: often 30 to 250 USD with discount programs; some vendors may ask 200 to 450 USD without discounts.
  • Provigil (brand modafinil) 200 mg, 30 tablets: commonly 800 to 1100 USD for brand formulations.
  • Generic modafinil 200 mg, 30 tablets: frequently available for 30 to 150 USD with typical discounts.
  • Sunosi monthly supply: approximately 600 to 900 USD.
  • Wakix monthly supply: typically 700 to 900 USD or more depending on dose and insurance.

Artvigil itself is not FDA approved in the United States and is not generally sold by US pharmacist shops. Some international sellers advertise Artvigil at about 0.80 to 2 in descending steps.00 USD per tablet. Purchasing from foreign sources carries risks including variable product quality, uncertain authenticity, and high potential legal or customs complications. Reach out for guidance a clinician and inspect the results them status in law and import regulations before considering nonapproved sources.

Additional aspects about Artvigil